Midgard Science

Labs / Assays & in vitro testing

A28 Therapeutics

La Jolla, CA, United States · a28therapeutics.com

On your own

Free. Their own form.

Contact A28 Therapeutics directly

Through Midgard

Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.

Request a quote through Midgard

A28 Therapeutics is a clinical-stage biopharmaceutical company focused on developing targeted oncolytic peptides for the treatment of multiple cancer types. It is based in La Jolla, California, and its lead compound AT-101 is being developed for metastatic ovarian cancer with liver metastases, hepatocellular carcinoma, and other solid tumors with liver metastases.

Their website has a general contact form; we send your quote request through it.

What they offer

  • Targeted oncolytic peptide platform development

    Develops a TOP platform based on conjugates of the CLYP-71 oncolytic peptide and targeting units for cancer treatment.

  • AT-101 development

    Advances AT-101 as a lead targeted oncolytic peptide candidate in late-stage clinical development.

  • Combination therapy development

    Studies AT-101 in combination with immuno-oncology therapeutics, checkpoint inhibitors, PARP inhibitors, and chemotherapy.

What they work on

Modalities
Antibody, Peptide, Cell therapy
Scale and capacity
production scaled to Kg levels
Therapeutic areas
cancer, metastatic ovarian cancer with liver metastases, hepatocellular carcinoma, solid tumors with liver metastases, hematological malignancies
Sites
La Jolla, United States
Serves
worldwide
Address
7660 Fay Ave H-829 La Jolla, CA 92037
Founded
2021

Similar labs. Avantia Labs, Oncodesign Services, 3C Therapeutics, Abeomics

Found in a contract services directory. Listing built from a28therapeutics.com. Work here? Claim this listing.

A28 Therapeutics · Midgard Science